SOPH · SOPHiA GENETICS SA

Track SOPH — free

$8.39 +0.32 (+3.98%) At close · Oct 5

Rebalance outlook locked

Market Cap

$709.97M

85.13M

Volume · Oct 5 1.18M Avg daily vol (3M) 525.46K

Up next

Next earnings call

Nov 3, 2026 Est · unconfirmed · in 4 wks

Q2 2026 earnings call transcript

call held Aug 4, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$86.17M

Trailing 12 months

Net income (TTM)

$77.12M

Trailing 12 months

Revenue growth YoY

+27.2%

Year over year

Operating margin

-85.5%

Trailing 12 months

P / E (TTM)

9.2

Trailing earnings · reciprocal yield 10.9%

FCF yield

-5.8%

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

$59.67M

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+2.7%

Year over year · more shares

Price change (1Y)

+80.5%

Trailing year

Short interest

1.3%

Latest settlement · 1.7 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Buy Momentum Strong Sentiment Bullish Fundamentals Limited Quant / Vol Very High

Market backdrop VIX 15.3 · calm Equity put/call 0.59

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +42%

above

Price vs 50-day avg +5%

above

RSI (14) 50

neutral

MACD trend Negative

52-week position 83%

mid-range

Volume (OBV) Bullish div.

accumulating

Momentum

relative strength

Strong

1-month return −3%

trailing

6-month return +66%

trailing

YTD return +73%

this year

Relative strength +54%

vs S&P · 6-mo

Sentiment

smart money

Bullish

Trend (MA cross) No cross

50d $8 › 200d $6 — 50d above 200d

Institutional flow Accumulating

+44% holders QoQ · +25 funds added

Insider flow Distributing

Net -$39.4K over 90 days · 100% sells

Short interest Falling

1.26% of float · ▼ -3.0% MoM · 1.7 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

72 holders — near 3-yr high, broad support

Squeeze score 48

elevated · 0–100

Fundamentals

Limited

Not enough data for a confident read.

Quant / Vol

risk profile

Very High

Volatility 64%

annualized · 1-yr

Max drawdown −26%

past year

ATR 5.5%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the Earnings Call filed Aug 4, 2026

Full year revenue · full year 2026 Initiated $94M – $96M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy

1 · 3 · 3

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+42% Bullish

Price vs 50-day avg

+5% Bullish

RSI (14)

50 Neutral

MACD trend

Negative Bearish

52-week position

83% Neutral

Volume (OBV)

Bullish div. Bullish

Market signals — smart money & positioning

Bullish · 3 of 6

Trend (MA cross) No cross

50d $8 › 200d $6 — 50d above 200d

Institutional flow Accumulating

+44% holders QoQ · +25 funds added

Insider flow Distributing

Net -$39.4K over 90 days · 100% sells

Short interest Falling

1.26% of float · ▼ -3.0% MoM · 1.7 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

72 holders — near 3-yr high, broad support

Price context

position in its 52-week range

Range low $4 Now $8 · 83% Range high $9

vs 200-day avg +42% vs 50-day avg +5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Health Information Services — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
SOPH SOPHiA GENETICS SA this stock	$709.97M	+72.8%	—	—	1.3%
VEEV Veeva Systems Inc	$45.44B	+22.4%	+28.1%	45.9	3.1%
TEM Tempus AI, Inc.	$15.34B	+29.8%	+83.4%	—	15.6%
PMDIY Pro Medicus Ltd./ADR	$12.20B	-29.7%	—	—	0.0%
BTSG BrightSpring Health Services, Inc.	$11.02B	+60.9%	+28.2%	33.8	5.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

% held: 44.0%
Net QoQ: +13.1M sh
Top holder: GENERATION INVESTMENT MAN…

Held Float

View

Held by Funds

Fund positions

View

Short & Settlement

Short Interest Falling

Shares short

1.1M

Days to cover: 1.7d
Change: -33.6K sh

View

Short Volume

Short vol %

21%

As of: Oct 5, 2026

Short Total

View

Fails to Deliver

FTD shares

2.1K

Value: $16.3K
As of: Sep 14, 2026

View

Off-Exchange

Off-exchange %

60.6%

Week of: Aug 31, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$39.4K

Buyers / Sellers: 0 / 1

Buyers Sellers

View

Filings

SEC Filings

Latest

6-K

Filed: Aug 4, 2026
This year: 13

View

Proposed Sales

Value

$49.8K

Shares: 6.2K
Filed: Oct 5, 2026

View

Earnings & Events

Webcasts

Last webcast

Aug 4, 2026

View

Performance

	5D	20D	120D	MTD	YTD
SOPH	-3.2%	-2.8%	+66.4%	-3.7%	+72.8%
SPY	-0.2%	-0.5%	+12.2%	+0.9%	+12.9%
vs SPY	-3.0%	-2.3%	+54.2%	-4.6%	+60.0%

Key facts CIK 1840706 CUSIP H82027105 13F (30d) 1 filings 1 filers Visit website Investor relations

SOPH · SOPHiA GENETICS SA

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Versus peers

At a glance

Performance